Literature DB >> 17998320

Optimising corticosteroid treatment for autoimmune pancreatitis.

Amaar Ghazale1, Suresh T Chari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17998320      PMCID： PMC2095689          DOI： 10.1136/gut.2007.129833

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

2.  Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment.

Authors:  Tokio Wakabayashi; Yukimitsu Kawaura; Yositake Satomura; Hiroyuki Watanabe; Yoshiharu Motoo; Norio Sawabu
Journal:  Pancreas       Date:  2005-01       Impact factor: 3.327

3.  Biliary tract involvement in autoimmune pancreatitis.

Authors:  Takayoshi Nishino; Fumitake Toki; Hiroyasu Oyama; Itaru Oi; Makio Kobayashi; Ken Takasaki; Keiko Shiratori
Journal:  Pancreas       Date:  2005-01       Impact factor: 3.327

4.  Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens.

Authors:  Giuseppe Zamboni; Jutta Lüttges; Paola Capelli; Luca Frulloni; Giorgio Cavallini; Paolo Pederzoli; Alexander Leins; Daniel Longnecker; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-10-27       Impact factor: 4.064

Review 5.  Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.

Authors:  K Wang; H Zhang; Y Li; Q Wei; H Li; Y Yang; Y Lu
Journal:  Transplant Proc       Date:  2004-09       Impact factor: 1.066

Review 6.  Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.

Authors:  Chinyu Su; Gary R Lichtenstein
Journal:  Gastroenterol Clin North Am       Date:  2004-06       Impact factor: 3.806

Review 7.  Autoimmune chronic pancreatitis.

Authors:  Kyu-Pyo Kim; Myung-Hwan Kim; Moon Hee Song; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

8.  Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.

Authors:  Kenji Hirano; Minoru Tada; Hiroyuki Isayama; Hiroshi Yagioka; Takashi Sasaki; Hirofumi Kogure; Yousuke Nakai; Naoki Sasahira; Takeshi Tsujino; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gut       Date:  2007-05-24       Impact factor: 23.059

9.  A new clinicopathological entity of IgG4-related autoimmune disease.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi; Yoshinobu Eishi; Morio Koike; Kouji Tsuruta; Atsutake Okamoto; Naoto Egawa; Hitoshi Nakajima
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

10.  Morphological changes after steroid therapy in autoimmune pancreatitis.

Authors:  T Kamisawa; N Egawa; H Nakajima; K Tsuruta; A Okamoto
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423
View more
  23 in total

1.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

2.  Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.

Authors:  Kensuke Kubota; Seitaro Watanabe; Takashi Uchiyama; Shingo Kato; Yusuke Sekino; Kaori Suzuki; Hironori Mawatari; Hiroshi Iida; Hiroki Endo; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Satoru Saito; Kazuya Sugimori; Kantaro Hisatomi; Nobuyuki Matsuhashi; Hirotaka Sato; Emiko Tanida; Takashi Sakaguchi; Nobutaka Fujisawa; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-04-15       Impact factor: 7.527

3.  Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Tetsuhide Ito; Kazuo Inui; Hiroyuki Irie; Takayoshi Nishino; Kenji Notohara; Isao Nishimori; Shigeki Tanaka; Toshimasa Nishiyama; Koichi Suda; Keiko Shiratori; Masao Tanaka; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-03-18       Impact factor: 7.527

4.  Treatment and relapse of autoimmune pancreatitis.

Authors:  Sung-Hoon Moon; Myung-Hwan Kim; Do Hyun Park
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

5.  Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis.

Authors:  Tsukasa Ikeura; Riccardo Manfredi; Giuseppe Zamboni; Riccardo Negrelli; Paola Capelli; Antonio Amodio; Anna Caliò; Giulia Colletta; Armando Gabbrielli; Luigi Benini; Kazuichi Okazaki; Italo Vantini; Luca Frulloni
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

6.  Unusual cause of maxillary sinus mass with proptosis.

Authors:  Regi Kurien; Telugu Ramesh Babu; Vedantam Rupa
Journal:  BMJ Case Rep       Date:  2015-09-21

Review 7.  Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP.

Authors:  Terumi Kamisawa; Kazuichi Okazaki; Shigeyuki Kawa; Tooru Shimosegawa; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

8.  IgG4-related systemic sclerosing disease: a diagnosis to be considered!!

Authors:  Bobby V M Dasari; Kevin McElvanna; Maurice Loughrey; Tom Diamond
Journal:  BMJ Case Rep       Date:  2013-03-28

9.  Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.

Authors:  Bin Liu; Jing Li; Lu-Nan Yan; Hao-Ran Sun; Tong Liu; Zhi-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 10.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.